Rational Drug Design: The Search for Ras Protein Hydrolysis Intermediate Conformation Inhibitors with Both Affinity and Specificity

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|12|2246-2258

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.12, 2013-04, pp. : 2246-2258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Design for Protein Kinases and Phosphatases: Flexible-Receptor Docking, Binding Affinity and Specificity, and Drug-Binding Kinetics

By  

Current Pharmaceutical Design, Vol. 19, Iss. 26, 2013-08 ,pp. : 4739-4754

Bentham Science Publishers

Access to resources Recommend Favorite

Rational Drug Design of DNA Oligonucleotides as HIV Inhibitors

By  

Current Drug Targets - Infectious Disorders, Vol. 1, Iss. 2, 2001-08 ,pp. : 79-90

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in Rational Drug Design of Neuraminidase Inhibitors

By  

Current Medicinal Chemistry, Vol. 14, Iss. 27, 2007-11 ,pp. : 2872-2891

Bentham Science Publishers

Access to resources Recommend Favorite

Protein crystallization in drug design: towards a rational approach

By Derewenda Zygmunt S  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 10, 2007-10 ,pp. : 1329-1340

Informa Healthcare

Access to resources Recommend Favorite

Structure and Ligand Based Rational Drug Design for Bace-1 Inhibitors

By  

Current Bioactive Compounds, Vol. 9, Iss. 1, 2013-03 ,pp. : 14-20

Bentham Science Publishers

Access to resources Recommend Favorite